Gabriel Kwaku Agbeshie

Gabriel Kwaku Agbeshie

Auto-generated profile, based on publicly available information

Gabriel Kwaku Agbeshie

Department of Optometry and Visual Science, College of Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2025 in Open Research Europe
Verified
Journal Article
Open access
GAGabriel Kwaku Agbeshie
Gabriel Kwaku Agbeshie
IJIsaiah Osei Duah Junior
Isaiah Osei Duah Junior
Albert Kwadjo Amoah AndohAlbert Kwadjo Amoah Andoh
Albert Kwadjo Amoah Andoh
JAJosephine Ampong
Josephine Ampong
NMNana Akwasi Owusu Mensah
Nana Akwasi Owusu Mensah
KAKwadwo Owusu Akuffo
Kwadwo Owusu Akuffo
Light plays a significant role in human physiology and behaviour, influencing sleep, mood, alertness and overall health. Yet light exposure remains a neglected determinant of health, with most evidence coming from high-income countries. This data note presents a dataset collected in Kumasi, Ghana, between October 2024 and February 2025, containing personal light exposure measured with wearable melanopic light loggers alongside behavioural and environmental factors obtained through self-reports. Fifteen participants (n=8 female, mean±SD age 22.6±1.2 years) wore three ActLumus light-logging devices continuously for seven days, recording light exposure every 10 seconds at the near-corneal plane, chest and wrist. Participants also completed daily questionnaires on sleep, mood and physical activity, as well as structured assessments of their sleep environment and light-related behaviours. This dataset provides the first high-resolution account of daily light exposure in sub-Saharan Africa. By enabling cross-context comparisons, it contributes to understanding the diversity of light environments globally and can inform interventions for sleep health, mental health and chronic disease prevention.

25 September 2025 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
JAJosephine Ampong
Josephine Ampong
SASylvia Agyekum
Sylvia Agyekum
WEWerner Eisenbarth
Werner Eisenbarth
Albert Kwadjo Amoah AndohAlbert Kwadjo Amoah Andoh
Albert Kwadjo Amoah Andoh
Isaiah Osei Duah JuniorIsaiah Osei Duah Junior
Isaiah Osei Duah Junior
KAKwadwo Owusu Akuffo
Kwadwo Owusu Akuffo
Artificial intelligence (AI) has transformed healthcare, and is becoming increasingly useful in eye care. We conducted a systematic review and meta-analysis of the use of AI in the diagnosis, detection, prediction, progression, and treatment of refractive errors (REs). The study adhered to the PRISMA checklist to ensure transparent reporting. The following databases were searched from inception to January 2025, with an English language restriction: PubMed, Web of Science, Embase, Scopus, Cochrane Library and Google Scholar. Two independent reviewers performed study screening, data extraction, and quality assessment, with a third author resolving discrepancies. All original studies on the use of AI techniques in RE were identified and the effectiveness of these techniques was compared. A critical appraisal was conducted using the QUADAS-2 risk-of-bias tool. A meta-analysis was performed using R software (version 4.5.0). Of 6,288 records retrieved, 45 met eligibility for systematic review, with 19 included in meta-analysis. Among these 45 studies, 55.5% (25/45) applied deep learning (DL) approaches, while 44.4% (20/45) employed machine learning (ML) techniques. The pooled sensitivity, specificity, diagnostic odds ratio (DOR), and summary of receiver operating characteristic (SROC) for detection and/or diagnosis studies were 0.94 (95%CI, 0.90-0.97), 0.96 (95%CI, 0.92-0.98), 382.56 (95% CI 111.91 -1307.77) and 0.98 (95%CI, 0.91-0.97), respectively. For prediction of REs, the pooled sensitivity, specificity, DOR, and SROC were 0.87 (95%CI, 0.73-0.94), 0.96 (95%CI, 0.90-0.980), 159.94 (95% CI, 40.17-636.85) and 0.96 (95%CI, 0.85-0.95), respectively. Among studies focused on progression, performance metrics ranged from AUC = 0.845-0.99, R² = 0.613-0.964, and MAE = 0.119D-0.49D. In treatment studies, performance varied more widely, with AUC values between 0.60–0.94 and MAE from 0.17D-0.54D. Collectively, AI technologies, particularly DL and ML, achieved high diagnostic and predictive accuracy in RE management. Future research should focus on developing generalizable models trained on diverse datasets to ensure broad clinical relevance.

13 February 2024 in medRxiv
Verified
Preprint
Open access
PDF file
CGCarolina Guidolin
Carolina Guidolin
Sam AertsSam Aerts
Sam Aerts
GAGabriel Kwaku Agbeshie
Gabriel Kwaku Agbeshie
KAKwadwo Owusu Akuffo
Kwadwo Owusu Akuffo
SASema Nur Aydin
Sema Nur Aydin
Manuel SpitschanManuel Spitschan
Manuel Spitschan
Light profoundly impacts many aspects of human physiology and behaviour, including the synchronization of the circadian clock, the production of melatonin, and cognition. These effects of light, termed the non-visual effects of light, have been primarily investigated in laboratory settings, where light intensity, spectrum and timing can be carefully controlled to draw associations with physiological outcomes of interest. Recently, the increasing availability of wearable light loggers has opened the possibility of studying personal light exposure in free-living conditions where people engage in activities of daily living, yielding findings associating aspects of light exposure and health outcomes, supporting the importance of adequate light exposure at appropriate times for human health. However, comprehensive protocols capturing environmental (e.g., geographical location, season, climate, photoperiod) and individual factors (e.g., culture, personal habits, behaviour, commute type, profession) contributing to the measured light exposure are currently lacking. Here, we present a protocol that combines smartphone-based experience sampling (experience sampling implementing Karolinska Sleepiness Scale, KSS ratings) and high-quality light exposure data collection at three body sites (near-corneal plane between the two eyes mounted on spectacle, neck-worn pendant/badge, and wrist-worn watch-like design) to capture daily factors related to individuals’ light exposure. We will implement the protocol in an international multi-centre study to investigate the environmental and socio-cultural factors influencing light exposure patterns in Germany, Ghana, Netherlands, Spain, Sweden, and Turkey (minimum n=15, target n=30 per site, minimum n=90, target n=180 across all sites). With the resulting dataset, lifestyle and context-specific factors that contribute to healthy light exposure will be identified. This information is essential in designing effective public health interventions.

9 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
Johannes ZaunerJohannes Zauner
Johannes Zauner
ADAltug Didikoglu
Altug Didikoglu
Sam AertsSam Aerts
Sam Aerts
GAGabriel Kwaku Agbeshie
Gabriel Kwaku Agbeshie
KAKwadwo Owusu Akuffo
Kwadwo Owusu Akuffo
Manuel SpitschanManuel Spitschan
Manuel Spitschan
Personal light exposure is a modifiable component of the health exposome, but its everyday determinants remain poorly understood. We conducted an observational, harmonised, multi-country wearable study of ocular light exposure in 191 adults across nine sites in Sweden, the Netherlands, Germany, Spain, Turkey, Costa Rica, and Ghana, comprising 1,480 participant-days. Participants wore calibrated light loggers near the corneal plane and at chest level and completed repeated contextual assessments. Average daytime exposure remained below recommended melanopic levels, with adherence varying by site, daily phase and photoperiod. Exposure generally increased with latitude despite greater year-round sunlight at lower latitudes, consistent with behavioural filtering through shade-seeking, indoor living or heat avoidance. Individual and activity-level differences explained more variation than site. Daylight access, outdoor activity and micro-environment were the strongest correlates. These findings support personalized, context-sensitive light interventions and establish ocular light exposure as a measurable exposomic factor relevant to health.

12 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
GAGabriel Kwaku Agbeshie
Gabriel Kwaku Agbeshie
Isaiah Osei Duah JuniorIsaiah Osei Duah Junior
Isaiah Osei Duah Junior
Albert Kwadjo Amoah AndohAlbert Kwadjo Amoah Andoh
Albert Kwadjo Amoah Andoh
JAJosephine Ampong
Josephine Ampong
NMNana Akwasi Owusu Mensah
Nana Akwasi Owusu Mensah
KAKwadwo Owusu Akuffo
Kwadwo Owusu Akuffo
Light plays a significant role in human physiology and behaviour, influencing sleep, mood, alertness and overall health. Yet light exposure remains a neglected determinant of health, with most evidence coming from high-income countries. This data note presents a dataset collected in Kumasi, Ghana, between October 2024 and February 2025, containing personal light exposure measured with wearable melanopic light loggers alongside behavioural and environmental factors obtained through self-reports. Fifteen participants (n=8 female, mean±SD age 22.6±1.2 years) wore three ActLumus light-logging devices continuously for seven days, recording light exposure every 10 seconds at the near-corneal plane, chest and wrist. Participants also completed daily questionnaires on sleep, mood and physical activity, as well as structured assessments of their sleep environment and light-related behaviours. This dataset provides the first high-resolution account of daily light exposure in sub-Saharan Africa. By enabling cross-context comparisons, it contributes to understanding the diversity of light environments globally and can inform interventions for sleep health, mental health and chronic disease prevention. Plain language summary Light affects how we sleep, feel and stay healthy. But most research on light exposure has been carried out in high-income countries, meaning we know very little about people’s real-life light environments in other parts of the world. This study provides the first detailed dataset of daily light exposure in sub-Saharan Africa. Fifteen young adults in Kumasi, Ghana, wore small devices that measured the light around them every few seconds for one week, while also answering short questions about their sleep, mood and daily routines. The dataset shows how people in Ghana experience light in everyday life and allows comparisons with data from other countries. By making this resource openly available, we hope to support future research on how light exposure influences sleep, mental health and the risk of long-term diseases — helping to shape healthier light environments worldwide.

9 October 2025 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
MAMohammed Abdul-Kabir
Mohammed Abdul-Kabir
PMPrince Mintah
Prince Mintah
MAMichael Kwesi Asante
Michael Kwesi Asante
JFJames Forson
James Forson
AOAgnes Oppong
Agnes Oppong
SOStephanie Obeng-Inkoom
Stephanie Obeng-Inkoom
Glaucoma, characterized by chronic and progressive degeneration of retinal ganglion cells leading to a gradual decline in the visual field, poses a significant challenge in eye care delivery. Optometrists play a vital role in detecting and managing glaucoma. This study aims to determine how Ghanaian optometrists manage ocular adverse reactions (OADRs) in patients using antiglaucoma medications. A cross-sectional survey was conducted among 139 licensed optometrists using a pre-tested, semi-structured questionnaire. Data collected included socio-demographic characteristics, reported adverse reactions, and awareness of reporting or management protocols. Descriptive and inferential statistics were performed using SPSS version 25.0. Participants had a mean age of 31.6 ± 5.5 years and an average practice experience of 5.6 ± 4.5 years. Most respondents were female (71.2%), with 36.7% practicing in Greater Accra and 32.0% in private facilities. Nearly all participants (92.8%) reported encountering OADRs to AGMs. The most common symptoms were red eyes (36.0%), stinging (26.1%), burning sensation (25.4%), and itching (8.8%), while clinical signs included conjunctival hyperemia (45.5%), tear film deficiency (26.0%), and iris pigmentation changes (9.8%). Latanoprost (32.2%), timolol (23.7%), travoprost (17.6%), and brimonidine (10.2%) were the medications most frequently associated with these reactions. Optometrists primarily managed cases by switching to alternative medications (41.0%) or adjusting dosage and frequency (9.7%). However, 77.7% reported having no knowledge of existing protocols, and confidence in managing OADRs was moderately low (mean = 2.67 ± 0.49 on a 5-point scale). No significant association was found between OADR reporting and either age (p = 0.616) or years of practice (p = 0.974). These findings highlight that although OADRs are common in glaucoma management, optometrists in Ghana often lack standardized protocols and report low confidence in handling such cases. Targeted professional development and refresher training are needed to strengthen OADRs recognition, reporting, and management, ultimately improving patient eye care.